MedTrace Logo

Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation

NCT00608231 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2014-07-01

No results posted yet for this study

Summary

To test the hypothesis that sedation induced by Dexmedetomidine at levels appropriate for awake, DBS surgery has no significant effect on electrophysiological parameters of DBS micro-electrode recordings

Conditions

Interventions

DRUG

Dexmedetomidine Hydrochloride Infusion

Dexmedetomidine Hydrochloride Infusion(0.5-1.0 mg/kg)intravenous over 10 minutes with dose adjustment for goal Richmond Agitation and Sedation Scale of -1 During deep brain stimulator implantation surgery

DRUG

Normal Saline

Normal Saline intravenous over 10 minutes during deep brain stimulator implantation surgery

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Joseph Neimat, M.D. · Vanderbilt University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00608231 on ClinicalTrials.gov